Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
109(c) 108.58(c) 106.42(c) 105(c) 105.11(c) Last
7 297 958 4 518 049 7 104 939 4 237 622 4 404 521 Volume
+1.12% -0.39% -1.99% -1.33% +0.10% Change
More quotes
Financials (USD)
Sales 2020 33 885 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 438 M - -
P/E ratio 2020 42,9x
Yield 2020 1,38%
Sales 2021 38 360 M - -
Net income 2021 5 807 M - -
Net Debt 2021 8 390 M - -
P/E ratio 2021 33,4x
Yield 2021 1,51%
Capitalization 186 B 186 B -
EV / Sales 2020 5,82x
EV / Sales 2021 5,07x
Nbr of Employees 107 000
Free-Float 88,8%
More Financials
Company
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the... 
More about the company
Notations Surperformance© of Abbott Laboratories
Trading Rating : Investor Rating :
More Ratings
All news about ABBOTT LABORATORIES
09:01aABBOTT : Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip&..
PR
10/29United to give travelers free COVID-19 tests on select Newark-London flights
RE
10/28Combined Market Cap of Five Largest MedTech Companies Surged by $40bn YoY
AQ
10/28JPMorgan appoints General Dynamics CEO as board member
RE
10/28Boston Scientific reports loss as COVID-19 slams demand for medical devices
RE
10/23GLOBAL MARKETS LIVE : Intel, Mattel, Nordea…
10/22Quest raises profit forecast as COVID-19 tests demand to jump
RE
10/22ABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
10/21ABBOTT : 3Q Earnings Snapshot
AQ
10/21ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
10/21Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
10/21ABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
More news
News in other languages on ABBOTT LABORATORIES
10/26AVIS D'ANALYSTES DU JOUR : Adidas, Chargeurs, Daimler, EDF, Ipsen, L'Oréal, SAP,..
10/26Seconde vague
10/23Les résultats et les couvre-feux se ramassent à la pelle
10/23EN DIRECT DES MARCHES : Air Liquide, Renault, Accor, Faurecia, Kering, Airbus, I..
10/22ABBOTT : bien orienté avec des propos de broker
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 117,78 $
Last Close Price 105,11 $
Spread / Highest target 23,7%
Spread / Average Target 12,1%
Spread / Lowest Target -22,0%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES21.01%185 906
MEDTRONIC PLC-10.65%136 283
BECTON, DICKINSON AND COMPANY-14.52%67 386
HOYA CORPORATION12.92%45 242
BAXTER INTERNATIONAL INC.-6.63%39 527
SARTORIUS STEDIM BIOTECH120.72%35 041